Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT

被引:2
|
作者
Alem-Bezoubiri, Asma [1 ]
Ameir Suleiman, Suleiman [2 ]
Behidj, Ikram [3 ]
Mazrou, Hakim [4 ]
Chami, Ahmed Chafik [5 ]
机构
[1] Algiers Nucl Res Ctr CRNA, Med Phys Dept, Radiol Phys Div, 02 Blvd Frantz Fanon,BP 399 Alger RP, Algiers 16000, Algeria
[2] Tanzania Atom Energy Commiss, Radiat Control Directorate, POB 743, Arusha, Tanzania
[3] Cent Army Hosp, Radiotherapy Serv, Algiers, Algeria
[4] Algiers Nucl Res Ctr CRNA, Div Environm Safety & Radioact Waste, 02 Blvd Frantz Fanon,BP 399 Alger RP, Algiers 16000, Algeria
[5] Univ Sci & Technol Houari Boumediene, Fac Phys, USTHB, BP 32 EL ALIA, Algiers, Algeria
关键词
Prostate cancer; Secondary cancer risk; External beam radiotherapy; 3D conformal radiotherapy; Monte Carlo study; Out-of-field dose; DYNAMIC MLC IMRT; OF-FIELD ORGAN; LINEAR-ACCELERATOR; PROTON THERAPY; RADIOTHERAPY; SPECTRA; MV; PHANTOM; SIMULATION; EQUIVALENT;
D O I
10.1016/j.apradiso.2021.110065
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The present study aimed to evaluate organ doses and related risk for cancer from scattered neutrons involving 3D Conformational Radiotherapy (3D-CRT) for patients with prostate cancer in Algeria based on Monte Carlo technique and to estimate the secondary cancer risks. To this purpose, a detailed geometric Monte Carlo (MC) modeling of the LINAC Varian 2100C combined with a computational whole-body phantom was carried out. The neutron equivalent doses were calculated in-field and out-of field of patient's organs using the phase-space method. The obtained neutron equivalent doses were used to estimate the Lifetime Attributable Risks (LARs) for cancer incidence in out of field organs. LARs was evaluated assuming Biological Effects of Ionizing Radiation VII (BEIR VII) risk model for exposure age in the range 35-70 years, according to the interval's age of treated patients in Algeria. The baselines cancer risks and survival data were associated with the statistical data for the Algerian population. The results showed that the neutrons equivalent doses per prescribed dose (Photon Dose) mostly depend on the distance of organs from the treated volume. The highest and lowest equivalent doses of 1.18 mSv/Gy and 0.25 mSv/Gy were recorded in the bladder and heart, respectively. The highest estimated lifetime attributable risk per 100,000 population was found for 35 yrs' exposure age in colon 49.94, lung 16.63 and stomach 11.17. The lowest risks were found for 70 yrs' age, in spine 0.06 and thyroid 0.14. The results showed that LARs values decrease with the increase of the exposure age and cancer incidence risk is lower than the baseline cancer risk incidence for all organs. The present study may help in providing a database on the impact of radiotherapy-induced secondary cancer incidence during 3D-CRT for prostate cancer in Algeria.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Estimation of organs doses and radiation-induced secondary cancer risk from scattered photons for conventional radiation therapy of nasopharynx: a Monte Carlo study
    Asghar Mesbahi
    Farshad Seyednejad
    Amir Gasemi-Jangjoo
    Japanese Journal of Radiology, 2010, 28 : 398 - 403
  • [22] Estimation of organs doses and radiation-induced secondary cancer risk from scattered photons for conventional radiation therapy of nasopharynx: a Monte Carlo study
    Mesbahi, Asghar
    Seyednejad, Farshad
    Gasemi-Jangjoo, Amir
    JAPANESE JOURNAL OF RADIOLOGY, 2010, 28 (05) : 398 - 403
  • [23] bNED nnd side effects in 3D-CRT with 70/74 Gy in localised prostate cancer:: Results of a multicenter study
    Goldner, G.
    Zimmermann, F.
    Wachter, S.
    Becker, G.
    Geinitz, H.
    Wachter-Gestner, N.
    Reibenwein, J.
    Tomicek, B.
    Dimopoulos, J.
    Dorner, D.
    Glocker, S.
    Poetzi, R.
    Feldmann, H. J.
    Bamberg, M.
    Molls, M.
    Poetter, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 193 - 193
  • [25] An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours
    Lidestahl, Anders
    Mondlane, Gracinda
    Gubanski, Michael
    Lind, Pehr A.
    Siegbahn, Albert
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2019, 60 : 120 - 126
  • [26] Cyberknife versus IMRT versus 3D CRT for lung cancer: A Monte Carlo comparative dosimetry study
    Guerrero, T
    Pawlicki, T
    Chen, Y
    Martin, D
    Ma, CM
    Le, QX
    RADIOLOGY, 2000, 217 : 409 - 409
  • [27] Anatomical variables may determine the value of IMRT in intermediate risk prostate cancer: A dosimetric evaluation between IMRT and 3D-Crt plans
    Kim, D
    Ostapiak, O
    Daves, I
    Finucane, M
    Johal, B
    Lukka, H
    Poon, I
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S31 - S31
  • [28] Anatomical variables may determine the value of IMRT in intermediate risk prostate cancer: A dosimetric evaluation between IMRT and 3D-CRT PLANS
    Kim, D
    Ostapiak, O
    Dayes, I
    Finucane, M
    Lukka, H
    Johal, B
    Poon, I
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S59 - S59
  • [29] Can NTCP Models Derived From 3D-CRT Data Be Used to Predict Gastrointestinal Toxicities for IMRT Prostate Cancer Patients?
    Troeller, A.
    Soehn, M.
    Yan, D.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [30] Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: Results of a prospective multicenter study
    Vavassori, Vittorio
    Fiorino, Claudio
    Rancati, Tiziana
    Magli, Alessandro
    Fellin, Gianni
    Baccolini, Michela
    Bianchi, Carla
    Cagna, Emanuela
    Mauro, Flora A.
    Monti, Angelo F.
    Munoz, Fernando
    Stasi, Michele
    Franzone, Paola
    Valdagni, Riccardo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05): : 1401 - 1410